Joslin Diabetes Center and Scientia Advisors Announce Strategic Marketing Agreement
Deal creates the industry's only "boardroom-to-bench-to-bedside" solution to help life science companies successfully compete in the diabetes market
January 23, 2012
Cambridge, MA - Scientia Advisors, a leading healthcare strategy consulting firm, and the Joslin Diabetes Center, the world's leading diabetes research and clinical care organization, today announced a strategic alliance that will deliver unique solutions for corporations seeking to enter- or grow their presence in the diabetes market.
Through this alliance, the two organizations will be able to help corporate clients develop and execute highly informed corporate, brand, and product decisions resulting in a competitive advantage in the diabetes market.
"Our partnership with the Joslin Diabetes Center enables us to help our clients develop and execute strategies that are informed by world-class diabetes researchers and clinicians," said Harry Glorikian, Managing Partner, Scientia Advisors. "Working together we can provide a true Boardroom-to-Bench-to-Bedside consulting solution that helps companies decide on what technologies to pursue, products to develop, and partnerships to form, and help them execute operationally in the market."
"Scientia Advisors is an ideal partner for the Joslin Diabetes Center," said John L. Brooks III, President and CEO of the Joslin Diabetes Center. "Because Scientia Advisors has such a strong scientific foundation, they will be able to effectively draw upon our collective expertise for the benefit of companies seeking to develop and market new products and cures for diabetes patients. We are excited to work with Scientia Advisors and engage more deeply with the industry."
Glorikian added, "Given the fast paced change and complexity in today's healthcare market real world knowledge and experience is needed to help companies succeed. This partnership exemplifies the true capabilities needed to help organizations across the healthcare landscape (Life Science Tools, In Vitro Diagnostics, Medical Device/Health IT, Nutrition and Therapeutics) reduce risk and increase success."
About Diabetes: According to the World Health Organization (WHO), 346 million people worldwide have diabetes and up to 1.7 billion people are at increased risk for the disease. More than 80% of diabetes deaths occur in low- and middle-income countries. WHO projects that diabetes related deaths will double between 2005 and 2030.
About Scientia Advisors
Scientia Advisors is a global strategy consulting firm focused on the healthcare market. Scientia Advisors works closely with senior management to develop corporate, division, and product strategies that leverage market opportunities and successfully navigate the rapidly evolving healthcare marketplace. Firms across the healthcare value chain rely on Scientia Advisors to help make the right decisions. Today, healthcare growth strategies from Scientia Advisors are propelling firms in pharma, biotech, medtech, IVD, nutrition and wellness, chemical, as well as consumer electronics and telecom. For more information, visit www.scientiaadv.com.
About Joslin Diabetes Center
Joslin Diabetes Center is the world's preeminent diabetes clinic, diabetes research center and provider of diabetes education. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure for the disease. Founded in 1898 by Elliott P. Joslin, M.D., Joslin is an independent nonprofit institution affiliated with Harvard Medical School. Joslin's Healthcare Services collaborates with healthcare organizations to develop educational programs and materials to extend Joslin's mission nationwide. For more information, visit www.joslin.org.
Scientia Advisors, LLC